Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

A Phase III Randomized, Double-Blind, Double Dummy, Multi-Center Study To Compare The Efficacy, Safety And Tolerability Of Tolterodine Extended Release Capsule With Tolterodine Immediate Release Tablet In Subjects With Symptoms Of Overactive Bladder

To evaluate efficacy of tolterodine extended release formulation compared with immediate release formulation in subjects with symptoms of overactive bladder

Inclusion Criteria:

• Subjects with a diagnosis of overactive bladder.

Exclusion Criteria:

• Subjects with significant stress incontinence as determined by the investigator.
• Subjects with recurrent urinary tract infections defined as treated for UTI; 5 times in the last year.